Cannabinoids and Epilepsy

Version anglaise seulement Plant-based drugs present unusual challenges in the pharmaceutical world with respect to large-scale cultivation, processing, quality, and consistency. In the case of Cannabis sativa L., considerable additional complexity derives from...

read more

The potential for medical use cannabis

It has been established that 40%–60% of medications on the global market originate from plant extracts, including recent, highly effective chemotherapy agents such as taxanes. The use of cannabinoids...

read more